tetraphenylphosphonium has been researched along with diethylstilbestrol in 3 studies
| Studies (tetraphenylphosphonium) | Trials (tetraphenylphosphonium) | Recent Studies (post-2010) (tetraphenylphosphonium) | Studies (diethylstilbestrol) | Trials (diethylstilbestrol) | Recent Studies (post-2010) (diethylstilbestrol) |
|---|---|---|---|---|---|
| 438 | 0 | 39 | 8,585 | 322 | 491 |
| Protein | Taxonomy | tetraphenylphosphonium (IC50) | diethylstilbestrol (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.5893 | |
| Estrogen receptor | Homo sapiens (human) | 0.1312 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.67 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.208 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Substance-K receptor | Homo sapiens (human) | 9.553 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 7.763 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 5.6 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.67 | |
| Thromboxane-A synthase | Homo sapiens (human) | 4.359 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 4.79 | |
| Adenosine receptor A2a | Homo sapiens (human) | 9.013 | |
| Adenosine receptor A1 | Homo sapiens (human) | 2.856 | |
| Mu-type opioid receptor | Homo sapiens (human) | 5.778 | |
| D(3) dopamine receptor | Homo sapiens (human) | 8.796 | |
| Delta-type opioid receptor | Homo sapiens (human) | 2.718 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 4.563 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.14 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.071 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.46 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1588 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcangeli, A; Becchetti, A; Del Bene, MR; Olivotto, M; Wanke, E | 1 |
| Höfer, M; Sigler, K | 1 |
| Bezkorovainy, A; Miller-Catchpole, R; Poch, M; Solberg, L | 1 |
3 other study(ies) available for tetraphenylphosphonium and diethylstilbestrol
| Article | Year |
|---|---|
Effects of inhibitors of ion-motive ATPases on the plasma membrane potential of murine erythroleukemia cells.
Topics: Adenosine Triphosphatases; Animals; Cell Membrane; Dicyclohexylcarbodiimide; Diethylstilbestrol; Leukemia, Erythroblastic, Acute; Membrane Potentials; Mice; Oligomycins; Onium Compounds; Organophosphorus Compounds; Ouabain; Potassium; Tumor Cells, Cultured; Vanadates | 1992 |
Activation of the plasma membrane H(+)-ATPase of Saccharomyces cerevisiae by addition of hydrogen peroxide.
Topics: Buffers; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Membrane; Dicyclohexylcarbodiimide; Diethylstilbestrol; Enzyme Activation; Hydrogen Peroxide; Hydrogen-Ion Concentration; NAD; Onium Compounds; Organophosphorus Compounds; Oxidation-Reduction; Oxygen Consumption; Potassium; Proton-Translocating ATPases; Saccharomyces cerevisiae | 1991 |
Ferrous iron uptake by Bifidobacterium bifidum var. pennsylvanicus: the effect of metals and metabolic inhibitors.
Topics: Bifidobacterium; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cations, Divalent; Copper; Diethylstilbestrol; Ferrous Compounds; Manganese; Nickel; Nigericin; Onium Compounds; Organophosphorus Compounds; Potassium Chloride; Protons; Solutions; Valinomycin; Vanadates; Vanadium; Zinc | 1987 |